40 results
8-K
EX-99.1
n3tbyz
31 Mar 21
AcelRx Pharmaceuticals Announces Appointment of
5:09pm
8-K
EX-99.2
gj308 qd6
30 Apr 20
AcelRx Announces DSUVIA® Milestone C Approval
8:24am
425
EX-99.2
5ynpie2q
30 Apr 20
Business combination disclosure
8:22am
425
EX-2.1
ek9078aaso4o5pemt
16 Mar 20
Business combination disclosure
3:22pm
PRE 14A
dckpjk0pw45n5 ss
3 May 19
Preliminary proxy
5:03pm
424B5
cn0vb2zhev57kv1dit8
13 Nov 18
Prospectus supplement for primary offering
5:16pm
424B5
md0z4fdc
9 Nov 18
Prospectus supplement for primary offering
7:06am